First Time Loading...
S

Samjin Pharmaceutical Co Ltd
KRX:005500

Watchlist Manager
Samjin Pharmaceutical Co Ltd
KRX:005500
Watchlist
Price: 19 750 KRW -0.25% Market Closed
Updated: May 17, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Income Statement

292.1B
+0.7%
Revenue
Growth Rates:
1 Year
+7%
3 Years
+24%
5 Years
+12%
7 Years
+22%
10 Years
+52%
20.5B
-1%
Operating Income
Growth Rates:
1 Year
-12%
3 Years
-36%
5 Years
-65%
7 Years
-51%
10 Years
-32%
18.9B
-11%
Net Income
Growth Rates:
1 Year
-14%
3 Years
-32%
5 Years
-24%
7 Years
-37%
10 Years
+140%

Earnings Waterfall
Samjin Pharmaceutical Co Ltd

Revenue
292.1B KRW
Cost of Revenue
-175.4B KRW
Gross Profit
116.7B KRW
Operating Expenses
-96.2B KRW
Operating Income
20.5B KRW
Other Expenses
-1.6B KRW
Net Income
18.9B KRW

Income Statement
Samjin Pharmaceutical Co Ltd

Rotate your device to view
Income Statement
Currency: KRW
Dec-2013 Mar-2014 Jun-2014 Sep-2014 Dec-2014 Mar-2015 Jun-2015 Sep-2015 Dec-2015 Mar-2016 Jun-2016 Sep-2016 Dec-2016 Mar-2017 Jun-2017 Sep-2017 Dec-2017 Mar-2018 Jun-2018 Sep-2018 Dec-2018 Mar-2019 Jun-2019 Sep-2019 Dec-2019 Mar-2020 Jun-2020 Sep-2020 Dec-2020 Mar-2021 Jun-2021 Sep-2021 Dec-2021 Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Sep-2023 Dec-2023
Revenue
Revenue
192 006
N/A
194 516
+1%
198 055
+2%
199 649
+1%
201 305
+1%
202 592
+1%
205 880
+2%
211 178
+3%
216 511
+3%
223 159
+3%
229 512
+3%
234 814
+2%
239 313
+2%
241 201
+1%
243 941
+1%
247 303
+1%
245 272
-1%
249 627
+2%
252 450
+1%
253 691
+0%
260 017
+2%
256 266
-1%
251 709
-2%
247 084
-2%
241 926
-2%
238 967
-1%
239 194
+0%
234 939
-2%
235 165
+0%
232 605
-1%
235 784
+1%
260 917
+11%
250 070
-4%
255 718
+2%
258 795
+1%
247 503
-4%
274 032
+11%
283 258
+3%
288 841
+2%
289 990
+0%
292 129
+1%
Gross Profit
Cost of Revenue
(75 040)
(75 856)
(80 543)
(84 022)
(89 314)
(91 934)
(92 716)
(95 571)
(96 673)
(100 558)
(104 173)
(108 133)
(109 966)
(110 807)
(111 233)
(111 063)
(109 290)
(111 142)
(111 544)
(113 432)
(117 237)
(117 010)
(116 543)
(116 466)
(121 213)
(122 591)
(126 944)
(125 946)
(124 649)
(123 520)
(124 830)
(135 359)
(132 238)
(137 912)
(142 793)
(142 040)
(156 297)
(163 454)
(170 572)
(173 929)
(175 447)
Gross Profit
116 965
N/A
118 659
+1%
117 511
-1%
115 626
-2%
111 991
-3%
110 657
-1%
113 164
+2%
115 607
+2%
119 839
+4%
122 602
+2%
125 339
+2%
126 682
+1%
129 347
+2%
130 395
+1%
132 709
+2%
136 240
+3%
135 982
0%
138 486
+2%
140 907
+2%
140 260
0%
142 779
+2%
139 256
-2%
135 165
-3%
130 617
-3%
120 714
-8%
116 376
-4%
112 251
-4%
108 994
-3%
110 516
+1%
109 086
-1%
110 954
+2%
125 559
+13%
117 832
-6%
117 806
0%
116 003
-2%
105 463
-9%
117 734
+12%
119 804
+2%
118 268
-1%
116 061
-2%
116 681
+1%
Operating Income
Operating Expenses
(86 873)
(88 554)
(86 203)
(84 050)
(80 414)
(79 272)
(80 183)
(80 286)
(83 873)
(85 874)
(87 860)
(86 857)
(87 289)
(90 455)
(91 100)
(89 976)
(89 035)
(89 129)
(88 890)
(87 049)
(84 087)
(79 612)
(76 724)
(75 200)
(75 817)
(75 705)
(75 561)
(77 015)
(78 274)
(79 688)
(81 486)
(82 802)
(83 921)
(86 264)
(90 323)
(93 888)
(94 550)
(94 979)
(95 663)
(95 357)
(96 197)
Selling, General & Administrative
(71 824)
(72 927)
(72 209)
(71 640)
(70 195)
(70 152)
(70 884)
(71 117)
(73 835)
(74 967)
(76 751)
(76 550)
(77 576)
(78 356)
(78 933)
(79 829)
(78 408)
(77 847)
(77 344)
(76 441)
(74 657)
(70 855)
(68 129)
(67 003)
(67 366)
(67 455)
(67 938)
(69 081)
(70 149)
(71 664)
(73 004)
(74 192)
(74 456)
(76 148)
(79 457)
(81 783)
(82 369)
(86 091)
(89 839)
(89 817)
(85 992)
Research & Development
(14 610)
(15 116)
(13 464)
(11 876)
(9 734)
(8 400)
(8 590)
(8 706)
(9 575)
(9 823)
(10 015)
(9 768)
(9 359)
(9 125)
(9 224)
(9 854)
(10 235)
(10 529)
(10 768)
(10 160)
(8 992)
(8 423)
(8 245)
(7 828)
(7 939)
(7 681)
(7 000)
(7 230)
(7 353)
(7 296)
(7 740)
(7 883)
(8 650)
(9 315)
(10 010)
(11 189)
(11 177)
0
0
(5 015)
(9 138)
Depreciation & Amortization
(438)
(458)
(477)
(481)
(486)
(478)
(467)
(463)
(463)
(471)
(480)
(488)
(354)
(347)
(318)
(294)
(392)
(416)
(440)
(449)
(437)
(447)
(463)
(481)
(512)
(670)
(723)
(805)
(771)
(817)
(832)
(818)
(815)
(841)
(895)
(956)
(1 004)
0
0
(525)
(1 067)
Other Operating Expenses
0
(53)
(53)
(53)
0
(242)
(242)
0
0
(613)
(614)
(51)
0
(2 627)
(2 625)
0
0
(337)
(338)
0
0
113
113
112
0
101
100
101
0
89
90
90
0
39
39
39
0
(8 888)
(5 824)
0
0
Operating Income
30 093
N/A
30 106
+0%
31 310
+4%
31 578
+1%
31 577
0%
31 386
-1%
32 981
+5%
35 320
+7%
35 965
+2%
36 728
+2%
37 479
+2%
39 825
+6%
42 058
+6%
39 939
-5%
41 608
+4%
46 264
+11%
46 947
+1%
49 357
+5%
52 017
+5%
53 211
+2%
58 693
+10%
59 645
+2%
58 442
-2%
55 418
-5%
44 896
-19%
40 671
-9%
36 690
-10%
31 979
-13%
32 242
+1%
29 398
-9%
29 468
+0%
42 757
+45%
33 911
-21%
31 541
-7%
25 680
-19%
11 574
-55%
23 184
+100%
24 824
+7%
22 605
-9%
20 704
-8%
20 484
-1%
Pre-Tax Income
Interest Income Expense
(1 564)
(1 542)
(1 420)
(1 133)
(1 005)
(869)
(799)
(774)
(657)
(580)
(450)
(385)
(192)
(89)
38
124
80
160
217
286
583
606
623
638
420
475
431
338
305
200
165
182
114
(148)
(204)
(900)
1 058
474
(594)
(1 076)
(4 657)
Non-Reccuring Items
(52)
0
0
0
(242)
0
0
(805)
(612)
0
0
0
(2 625)
0
0
(2 965)
(340)
0
0
0
117
0
0
0
103
0
0
0
91
0
0
0
39
0
0
0
783
0
0
783
16
Gain/Loss on Disposition of Assets
(14)
(16)
(16)
(16)
(47)
0
0
(55)
(11)
(9)
(16)
(5)
(5)
(7)
0
24
24
30
82
58
58
40
14
17
17
31
7
17
305
1 166
1 338
1 325
1 037
145
501
501
501
0
0
3
185
Total Other Income
162
122
(88)
(155)
(128)
(57)
(125)
(19)
(90)
(269)
(207)
(342)
(293)
(227)
(262)
(245)
(238)
(211)
(228)
(245)
(250)
(301)
(22 354)
(22 355)
(23 564)
(23 454)
(1 272)
(1 126)
(113)
(96)
(225)
(463)
(191)
(406)
(357)
(236)
(299)
1 243
82
62
(472)
Pre-Tax Income
28 623
N/A
28 670
+0%
29 784
+4%
30 272
+2%
30 156
0%
30 460
+1%
32 057
+5%
33 667
+5%
34 595
+3%
35 870
+4%
36 807
+3%
39 095
+6%
38 944
0%
39 618
+2%
41 385
+4%
43 203
+4%
46 472
+8%
49 337
+6%
52 088
+6%
53 309
+2%
59 202
+11%
59 989
+1%
36 725
-39%
33 719
-8%
21 872
-35%
17 723
-19%
35 855
+102%
31 206
-13%
32 830
+5%
30 666
-7%
30 745
+0%
43 800
+42%
34 911
-20%
31 133
-11%
25 620
-18%
10 939
-57%
25 226
+131%
26 542
+5%
22 093
-17%
20 476
-7%
15 557
-24%
Net Income
Tax Provision
(20 744)
(20 409)
(6 798)
(7 022)
(9 439)
(9 614)
(9 963)
(10 091)
(7 552)
(7 365)
(7 143)
(7 605)
(8 770)
(8 903)
(9 274)
(9 690)
(10 677)
(11 349)
(12 061)
(12 329)
(34 319)
(34 425)
(34 067)
(33 338)
(9 991)
(8 822)
(7 775)
(6 867)
(4 950)
(4 473)
(4 368)
(7 057)
(6 507)
(5 887)
(4 403)
(1 263)
(3 325)
(694)
381
859
3 349
Income from Continuing Operations
7 878
8 261
22 986
23 250
20 717
20 846
22 094
23 576
27 043
28 505
29 664
31 490
30 174
30 715
32 112
33 514
35 796
37 989
40 026
40 979
24 883
25 563
2 659
382
11 881
8 903
28 081
24 340
27 879
26 192
26 376
36 742
28 404
25 246
21 216
9 676
21 901
25 848
22 473
21 335
18 906
Income to Minority Interest
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
(7)
(4)
0
(4)
3
Net Income (Common)
7 878
N/A
8 261
+5%
22 986
+178%
23 250
+1%
20 717
-11%
20 846
+1%
22 094
+6%
23 576
+7%
27 043
+15%
28 505
+5%
29 664
+4%
31 490
+6%
30 174
-4%
30 715
+2%
32 112
+5%
33 514
+4%
35 796
+7%
37 989
+6%
40 026
+5%
40 979
+2%
24 883
-39%
25 563
+3%
2 659
-90%
382
-86%
11 881
+3 010%
8 903
-25%
28 081
+215%
24 340
-13%
27 879
+15%
26 192
-6%
26 376
+1%
36 742
+39%
28 404
-23%
25 246
-11%
21 216
-16%
9 676
-54%
21 894
+126%
25 843
+18%
22 469
-13%
21 331
-5%
18 908
-11%
EPS (Diluted)
656.5
N/A
688.41
+5%
1 915.5
+178%
1 937.5
+1%
1 726.41
-11%
1 737.16
+1%
1 841.16
+6%
1 964.66
+7%
2 253.58
+15%
2 375.41
+5%
2 472
+4%
2 624.16
+6%
2 514.5
-4%
2 559.58
+2%
2 676
+5%
2 792.83
+4%
2 983
+7%
3 165.75
+6%
3 335.5
+5%
3 414.91
+2%
2 073.58
-39%
2 130.25
+3%
221.58
-90%
31.83
-86%
990.08
+3 011%
741.91
-25%
2 340.08
+215%
2 028.33
-13%
2 323.25
+15%
2 182.66
-6%
2 143.93
-2%
2 986.49
+39%
2 308.75
-23%
2 052.02
-11%
1 724.5
-16%
762.52
-56%
1 727.82
+127%
1 976.85
+14%
1 725.59
-13%
1 666.88
-3%
1 459.66
-12%

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 138,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.